| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A phase III study comparing SB3 (a proposed trastuzumab biosimilar) and trastuzumab reference product in HER2-positive early breast cancer treated with neoadjuvant-adjuvant treatment: Final safety, immunogenicity and survival results
|
Pivot, X.
|
|
2018
|
93 |
C |
p. 19-27
|
artikel
|
| 2 |
Benefit of the nivolumab and ipilimumab combination in pretreated advanced melanoma
|
Tétu, Pauline
|
|
2018
|
93 |
C |
p. 147-149
|
artikel
|
| 3 |
Blood classification and blood response criteria in mycosis fungoides and Sézary syndrome using flow cytometry: recommendations from the EORTC cutaneous lymphoma task force
|
Scarisbrick, Julia J.
|
|
2018
|
93 |
C |
p. 47-56
|
artikel
|
| 4 |
Clonal evolution and heterogeneity in metastatic head and neck cancer—An analysis of the Austrian Study Group of Medical Tumour Therapy study group
|
Melchardt, Thomas
|
|
2018
|
93 |
C |
p. 69-78
|
artikel
|
| 5 |
Corrigendum to “Precision medicine for patients with advanced biliary tract cancers: An effective strategy within the prospective MOSCATO-01 trial” [Eur J Cancer 87 (2017) 122–130]
|
Verlingue, Loic
|
|
2018
|
93 |
C |
p. 156-157
|
artikel
|
| 6 |
Corrigendum to “Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective study*” [Eur J Cancer 91 (2018) 116–124]
|
Valpione, Sara
|
|
2018
|
93 |
C |
p. 158
|
artikel
|
| 7 |
Costs of screening for prostate cancer: Evidence from the Finnish Randomised Study of Screening for Prostate Cancer after 20-year follow-up using register data
|
Booth, Neill
|
|
2018
|
93 |
C |
p. 108-118
|
artikel
|
| 8 |
Diversity of brain metastases screening and management in non-small cell lung cancer in Europe: Results of the European Organisation for Research and Treatment of Cancer Lung Cancer Group survey
|
Levy, Antonin
|
|
2018
|
93 |
C |
p. 37-46
|
artikel
|
| 9 |
European Academy of Cancer Sciences—Designation of Comprehensive Cancer Centres of Excellence
|
Ringborg, Ulrik
|
|
2018
|
93 |
C |
p. 138-139
|
artikel
|
| 10 |
Hallmarks of cancer: The CRISPR generation
|
Moses, Colette
|
|
2018
|
93 |
C |
p. 10-18
|
artikel
|
| 11 |
Health-related quality of life of adjuvant chemotherapy with S-1 versus gemcitabine for resected pancreatic cancer: Results from a randomised phase III trial (JASPAC 01)
|
Hagiwara, Yasuhiro
|
|
2018
|
93 |
C |
p. 79-88
|
artikel
|
| 12 |
High-risk soft tissue sarcomas treated with perioperative chemotherapy: Improving prognostic classification in a randomised clinical trial
|
Pasquali, Sandro
|
|
2018
|
93 |
C |
p. 28-36
|
artikel
|
| 13 |
Integrative expression quantitative trait locus–based analysis of colorectal cancer identified a functional polymorphism regulating SLC22A5 expression
|
Zou, Danyi
|
|
2018
|
93 |
C |
p. 1-9
|
artikel
|
| 14 |
Is low survival for cancer in Eastern Europe due principally to late stage at diagnosis?
|
Minicozzi, Pamela
|
|
2018
|
93 |
C |
p. 127-137
|
artikel
|
| 15 |
Letter to the Editor regarding the paper by N. Azzam et al. ‘Germline polymorphisms on RET proto-oncogene involved in medullary thyroid carcinoma in a Druze family’
|
Mathiesen, Jes Sloth
|
|
2018
|
93 |
C |
p. 154-155
|
artikel
|
| 16 |
Perioperative chemotherapy with or without epidermal growth factor receptor blockade in unselected patients with locally advanced oesophagogastric adenocarcinoma: Randomized phase II study with advanced biomarker program of the German Cancer Society (AIO/CAO STO-0801)
|
Stahl, Michael
|
|
2018
|
93 |
C |
p. 119-126
|
artikel
|
| 17 |
Pulmonary nodules and immunotherapy: disease progression or toxicity of anti-PD1/anti-PDL1 checkpoint inhibitors?
|
Pradère, P.
|
|
2018
|
93 |
C |
p. 144-146
|
artikel
|
| 18 |
Randomised phase III trial of concurrent chemoradiotherapy with extended nodal irradiation and erlotinib in patients with inoperable oesophageal squamous cell cancer
|
Wu, Shi-Xiu
|
|
2018
|
93 |
C |
p. 99-107
|
artikel
|
| 19 |
The use of intensive radiological assessments in routine surveillance after treatment for head and neck cancer: An economic evaluation
|
Meregaglia, Michela
|
|
2018
|
93 |
C |
p. 89-98
|
artikel
|
| 20 |
Three synchronous malignancies in a patient with DICER1 syndrome
|
Moke, Diana J.
|
|
2018
|
93 |
C |
p. 140-143
|
artikel
|
| 21 |
Treatment-related hemophagocytic lymphohistiocytosis secondary to checkpoint inhibition with nivolumab plus ipilimumab
|
Satzger, Imke
|
|
2018
|
93 |
C |
p. 150-153
|
artikel
|
| 22 |
Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphoma
|
El-Galaly, Tarec Christoffer
|
|
2018
|
93 |
C |
p. 57-68
|
artikel
|
Tijdschrift beschrijving